What Happened?
San Diego, CA-based Reneo-Pharmaceuticals Appointed Niall odonnell as President, Chief Executive Officer and Director
About the Company
Reneo is a clinical stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases. Many of these diseases are associated with deficits in cellular metabolism and energy production. Our goal is to improve daily function and quality of life of patients suffering from these diseases, most specifically, by improving how their mitochondria work, preserving muscle function and preventing muscle injury, weakness and wasting.
About the Person
Niall odonnell is President, Chief Executive Officer and Director at Reneo Pharmaceuticals. Previously, Niall held various senior HR leadership roles in the industry.
Info Source
News
Short Profile